Keywords: nps, drug, osteoporosis, track, ph, ii/iii, pharmaceuticals

NPS drug for osteoporosis on track in Ph II/III

Article | 10 March 2003

Print This

NPS Pharmaceuticals has reported that preliminary results from a PhaseII/III trial of Preos, the firm's parathyroid hormone-based drug for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in